Y chromosome loss detected by FISH in bladder cancer

Tsai, 1990, Allelic losses of chromosomes 9, 11 and 17 in human bladder cancer, Cancer Res, 50, 44 Olumi, 1990, Allelic loss of chromosome 17p distinguishes high grade from low grade transitional cell carcinomas of the bladder, Cancer Res, 50, 7081 Knowles, 1993, Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms, Oncogene, 8, 1357 Dalbagni, 1993, Genetic alterations in bladder cancer, Lancet, 342, 469, 10.1016/0140-6736(93)91595-D Cairns, 1993, Preliminary mapping of the deleted region of chromosome 9 in bladder cancer, Cancer Res, 53, 1230 Coombs, 1991, Amplification and overexpression of c-erB-2 in transitional cell carcinoma of the urinary bladder, Br J Cancer, 63, 601, 10.1038/bjc.1991.139 Sauter, 1994, Physical deletion of the p53 gene in bladder cancer: detection by fluorescence in situ hybridization, Am J Pathol, 144, 756 Mitelman, 1991 Powell, 1990, Apparent correlation of sex chromosome loss and disease course in urothelial cancer, Cancer Genet Cytogenet, 50, 97, 10.1016/0165-4608(90)90242-3 Waldman, 1991, Centromeric copy number of chromosome 7 is strongly correlated with tumor grade and labeling index in human bladder cancer, Cancer Res, 51, 3807 Hopman, 1988, In situ hybridization as a tool to study numerical chromosome aberrations in solid bladder tumors, Histochemistry, 89, 307, 10.1007/BF00500631 UICC, 1978, 3 Mostofi, 1973 Moch, 1993, p53 and erbB-2 protein overexpression are early stage alterations in transitional cell carcinoma of the bladder, Virchows A, 423, 329, 10.1007/BF01607144 Moch H, Sauter G, Epper R, Mihatsch M, Gudat F, Waldman F: p53 but not erbB-2 expression is associated with rapid tumor cell proliferation in urinary bladder cancer. Hum Path (in press). Messing, 1987, Epidermal growth factor-interactions with normal and malignant epithelium: in vivo and in vitro studies, J Urol, 138, 1329, 10.1016/S0022-5347(17)43593-2 Sandberg, 1977, Chromosome markers and progression in bladder cancer, Cancer Res, 37, 2950 1992, Loss of the Y chromosome from normal and neoplastic bone marrows, Genes Chromosom Cancer, 5, 83, 10.1002/gcc.2870050112 Elfving, 1990, Trisomy 7, trisomy 10, and loss of the Y chromosome in short-term cultures of normal kidney tissue, Cytogenet Cell Genet, 53, 123, 10.1159/000132910 Casalone, 1992, Significance of the clonal and sporadic chromosome abnormalities in non-neoplastic renal tissue, Hum Genet, 90, 71, 10.1007/BF00210747 Wolman, 1993, Complementarity of interphase and metaphase chromosome analysis in human renal tumors, Genes Chrom Cancer, 6, 17, 10.1002/gcc.2870060105 Hopman, 1990, Detection of numerical chromosome aberrations in bladder cancer by in situ hybridization, Am J Pathol, 135, 1105 Meloni, 1993, A new approach in the diagnosis and follow-up of bladder cancer: FISH analysis of urine, bladder washings, and tumors, Cancer Genet Cytogenet, 71, 105, 10.1016/0165-4608(93)90015-E Tribukait, 1987, Flow cytometry in assessing the clinical aggressiveness of genito-urinary neoplasms, World J Urol, 5, 108, 10.1007/BF00327068 Lane, 1992, p53, guardian of the genome, Nature, 358, 15, 10.1038/358015a0 Dalbagni, 1993, Molecular genetic alterations of chromosome 17 and p53 nuclear overexpression in human bladder cancer, Diagn Mol Pathol, 2, 4, 10.1097/00019606-199303000-00002 Bartek, 1991, Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies, Oncogene, 6, 1699 Livingstone, 1992, Altered cell cycle arrest and gene amplification potential accompany loss of wide-type p53, Cell, 70, 923, 10.1016/0092-8674(92)90243-6 Yin, 1992, Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles, Cell, 70, 937, 10.1016/0092-8674(92)90244-7 Iggo, 1990, Increased expression of mutant forms of p53 oncogene in primary lung cancer, Lancet, 335, 675, 10.1016/0140-6736(90)90801-B Marks, 1991, Overexpression and mutation of p53 in epithelial ovarian cancer, Cancer Res, 51, 2979 Bodner, 1992, Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation, Oncogene, 743